Tioget Inhalation Capsules provide an established, clinically unified dry powder inhalation (DPI) therapy carefully developed for the continuous maintenance management and long-term stabilization of Chronic Obstructive Pulmonary Disease (COPD) and chronic respiratory pathways. In professional respiratory care, persistent parasympathetic signaling causes continuous smooth muscle constriction around the bronchial trees, reducing vital lung capacity and inducing air trapping. This advanced formulation delivers a precisely micro-dose micronized powder layout designed exclusively for targeted dry powder inhalation devices, expanding structural airways directly at the source without triggering broader systemic compound tracking complications.
The active component, Tiotropium Bromide (18 mcg), functions dynamically as a long-acting muscarinic antagonist (LAMA). Upon inhalation via a suitable device, the micronized dry powder hits the target respiratory fields to competitively and reversibly bind to muscarinic acetylcholine receptors—specifically the $M_3$ receptor subtypes located on airway smooth muscle linings. By blocking the binding of endogenous acetylcholine, it arrests parasympathetic-driven bronchoconstriction loops. Tiotropium exhibits a highly specialized kinetic selectivity, dissociating very slowly from $M_3$ receptors, which translates into a powerful, steady bronchodilating action that persists effectively over a full 24-hour cycle with a single daily dose.
Key Benefits
-
Stable 24-Hour Airway Opening: High-affinity LAMA action ensures clear, relaxed bronchial passages all day and night with just one capsule.
-
Targeted Dry Powder Action: Delivers micronized medicine directly into structural lung fields, bypassing the need for duplicate oral liquid matrices.
-
Reduces Trapped Air Volume: Drastically drops functional residual lung capacity issues, making breathing lighter and supporting increased physical movement.
-
Reduces Exacerbation Risks: Consistent maintenance tracking helps establish stable respiratory baselines, preventing sudden, panic-inducing chest flare-ups.
-
Precise Dosing Architecture: Every single inhalation capsule provides a perfectly calibrated 18 mcg track, backed by Healthgate’s strict pharmaceutical guidelines.
Directions for Use
-
Use exactly as directed by your pulmonologist or respiratory specialist.
-
Tioget Capsules are strictly for oral inhalation use only via an inhalation device (like a Rotahaler or Revolizer). Do not swallow these capsules orally.
-
Inhalation Step-by-Step: Open the inhalation device chamber. Remove a Tioget capsule from its protective packaging layout and place it firmly into the chamber base. Close the device tightly until it clicks, then press the piercing button to split open the shell structure. Breathe out completely away from the device to empty your lungs. Place the mouthpiece securely between your teeth and seal your lips around it. Breathe in through your mouth as deeply and rapidly as possible. You should hear the capsule spinning or rattling inside the chamber, indicating the dry powder is releasing correctly. Hold your breath for 5 to 10 seconds, then breathe out gently.
-
Open the device to check if any powder remains; if so, take another deep breath through the mouthpiece. Discard the empty gelatin shell configuration.
-
Important Hygiene Rule: Always rinse your mouth thoroughly with plain water and spit it out after completing your inhalation routine to prevent localized throat dryness or dry powder trace irritation.
Safety & Precautions
-
Do not alter your daily dosage or stop usage suddenly without professional tracking, as severe bronchospasms or severe breathlessness loops can return sharply.
-
Not for Acute Rescue Use: This product is a slow-acting maintenance medication. Do not use Tioget to treat a sudden, acute attack of breathlessness. Always ensure a dedicated short-acting rescue bronchodilator inhaler is accessible for acute emergencies.
-
Inform your specialist before initialization if you have an underlying personal history of closed-angle glaucoma, urinary retention patterns, or an enlarged prostate (anticholinergics can slightly alter localized fluid tracking parameters).
-
If you experience immediate worsening of breathing difficulties or unexpected chest tightness right after inhaling a dose (paradoxical bronchospasm), discontinue use instantly and use your rescue inhaler.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 25°C. Do not freeze.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Leave the capsules safely inside their original protective packaging configuration until the exact moment of use, as dry powder matrices are highly sensitive to ambient room humidity tracking.
